Another obstacle is that most cancers cells resist remedies as they mutate; e.g., genes resistant to drug (abca4 and abca12) were over-expressed in most human mcf-7 breast cancer cells when docetaxel was administered. This evidence concerns the gene ABCA4 and breast carcinoma.